BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice. ✅
Go to Publication ✅
Archives of Iranian medicine (Arch Iran Med ) Vol: 19 Issue 3 Pages: 197-203 Pub: 2016 Mar Epub: Authors Cao Y , Pan Q , Cai W , Shen F , Chen GY , Xu LM , Fan JG , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome In Vivo. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 1210 Pub: 2020 Epub: 2020 Aug 31 Authors Li L , Cui H , Li T , Qi J , Chen H , Gao F , Tian X , Mu Y , He R , Lv S , Chu F , Xu B , Wang P , Lei H , Xu H , Wang C , |
|
|
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 223 Pub: 2020 Epub: 2020 Mar 13 Authors Wu M , Yang S , Wang S , Cao Y , Zhao R , Li X , Xing Y , Liu L , |
|
|
Berberine Protects against High-Energy and Low-Protein Diet-Induced Hepatic Steatosis: Modulation of Gut Microbiota and Bile Acid Metabolism in Laying Hens. ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 24 Issue 24 Pages: Pub: 2023 Dec 9 Epub: 2023 Dec 9 Authors Wang C , Yang Y , Chen J , Dai X , Xing C , Zhang C , Cao H , Guo X , Hu G , Zhuang Y , |
|
|
Microbiome and metabolome analyses reveal significant alterations of gut microbiota and bile acid metabolism in ETEC-challenged weaned piglets by dietary berberine supplementation. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1428287 Pub: 2024 Epub: 2024 Jun 25 Authors Nie X , Lu Q , Yin Y , He Z , Bai Y , Zhu C , |
|
|
Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats. ✅
Go to Publication ✅
Obesity facts (Obes Facts ) Vol: 9 Issue 6 Pages: 365-378 Pub: 2016 Epub: 2016 Nov 30 Authors Sun H , Wang N , Cang Z , Zhu C , Zhao L , Nie X , Cheng J , Xia F , Zhai H , Lu Y , |
|
|
Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease. ✅
Go to Publication ✅
Clinical and translational medicine (Clin Transl Med ) Vol: 10 Issue 4 Pages: e112 Pub: 2020 Aug Epub: 2020 Aug 13 Authors Li S , Wang N , Tan HY , Chueng F , Zhang ZJ , Yuen MF , Feng Y , |
|
|
Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 107 Issue Pages: 1556-1563 Pub: 2018 Nov Epub: 2018 Sep 5 Authors Shi Y , Hu J , Geng J , Hu T , Wang B , Yan W , Jiang Y , Li J , Liu S , |
|
|
A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 11 Issue Pages: 588079 Pub: 2020 Epub: 2020 Sep 24 Authors Chen H , Zhang F , Zhang J , Zhang X , Guo Y , Yao Q , |
|
|
Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition. ✅
Go to Publication ✅
Journal of cellular and molecular medicine (J Cell Mol Med ) Vol: 26 Issue 4 Pages: 1060-1070 Pub: 2022 Feb Epub: 2022 Jan 5 Authors Zhao Y , Huang J , Li T , Zhang S , Wen C , Wang L , |
|
|
Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition. ✅
Go to Publication ✅
Journal of cellular and molecular medicine (J Cell Mol Med ) Vol: 26 Issue 4 Pages: 1060-1070 Pub: 2022 Feb Epub: 2022 Jan 5 Authors Zhao Y , Huang J , Li T , Zhang S , Wen C , Wang L , |
|
|
Effects of Berberine on Gut Microbiota in Patients with Mild Metabolic Disorders Induced by Olanzapine. ✅
Go to Publication ✅
The American journal of Chinese medicine (Am J Chin Med ) Vol: 49 Issue 8 Pages: 1949-1963 Pub: 2021 Epub: Authors Pu Z , Sun Y , Jiang H , Hou Q , Yan H , Wen H , Li G , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
